Principal Financial Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-168,690
Closed -$2.53M 2230
2016
Q2
$2.53M Buy
168,690
+4,518
+3% +$58K ﹤0.01% 1621
2016
Q1
$2M Buy
164,172
+6,634
+4% +$93K ﹤0.01% 1638
2015
Q4
$2.51M Buy
157,538
+7,381
+5% +$116K ﹤0.01% 1584
2015
Q3
$2.3M Buy
150,157
+11,372
+8% +$246K ﹤0.01% 1611
2015
Q2
$3.37M Sell
138,785
-1,597
-1% -$38.3K 0.01% 1556
2015
Q1
$3.26M Buy
140,382
+3,146
+2% +$83.3K ﹤0.01% 1536
2014
Q4
$3.45M Sell
137,236
-6,890
-5% -$202K 0.01% 1543
2014
Q3
$4.48M Buy
144,126
+6,390
+5% +$173K 0.01% 1388
2014
Q2
$3.56M Buy
137,736
+128,500
+1,391% +$2.85M 0.01% 1547
2014
Q1
$216K Sell
9,236
-88
-0.9% -$1.93K ﹤0.01% 2106
2013
Q4
$237K Buy
+9,324
New +$211K ﹤0.01% 2094

Principal Financial Group's SGNT Position: Q3 2016 in Review

Principal Financial Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 168,690 shares — an estimated $2.53M sold.

Principal Financial Group first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $4.48M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Principal Financial Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Principal Financial Group sold 168,690 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2.53M.
  • Principal Financial Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
  • Principal Financial Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4.48M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Principal Financial Group's 13F filing for Q3 2016, filed 10 Nov 2016.